comparemela.com

Latest Breaking News On - Shingo ito - Page 2 : comparemela.com

Ashurst advises Babcock in relation to sale of its UK Power business

Global law firm Ashurst has advised Babcock International Group PLC in relation to the sale of its UK Power business, Babcock Networks Limited to PAI

Ashurst advises on one of UK s first battery energy storage projects operated by Japanese companies

Global law firm Ashurst has represented Fuyo General Lease Co.,Ltd. in relation to participation in the development and operation of two battery

Tokyo robot cafe offers new spin on disability inclusion

At a Tokyo cafe, Michio Imai greets a customer, but not in person. He's hundreds of kilometres away, operating a robot waiter as part of an experiment in inclusive employment.

The just-food interview - Otokomae Tofuten Archives

The just-food interview - Otokomae Tofuten Archives
just-food.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from just-food.com Daily Mail and Mail on Sunday newspapers.

Could Peptide-Insulin Mixture Unlock the Prospect of Oral Diabetes Therapy?

Could Peptide-Insulin Mixture Unlock the Prospect of Oral Diabetes Therapy? April 28, 2021 The results of research by a team of scientists at Kumamoto University in Japan could feasibly provide the foundation for developing orally administered forms of insulin that would free diabetes patients from daily injections. The team’s studies first found that L-DNP peptide, a small intestine-permeable cyclic peptide originally used as an insulin additive to improve absorption into the small intestine, lowers blood glucose levels in mice. They then demonstrated that insulin can be administered orally by simply adding the D-form of the DNP peptide (D-DNP) to injectable insulin used in clinical practice. The results could represent the foundation for developing a more patient-friendly form of insulin therapy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.